HER2-targeted Therapy: Routes of Administration

Video

Evaluating the benefits of the subQ vs IV formulation of the trastuzumab-pertuzumab combination for the management of HER2+ breast cancer and examining the potential use of at-home administration.

Evaluating the benefits of the subQ vs IV formulation of the trastuzumab-pertuzumab combination for the management of HER2+ breast cancer and examining the potential use of at-home administration.

Recent Videos
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
Hand holding a container of Olanzapine, an atypical antipsychotic medication used to treat schizophrenia and bipolar disorder. Illustrative editorial taken in Vista, CA / USA on July 7, 2020

Opinion: Addition of Olanzapine Effectively Manages Nausea During T-DXd Treatment

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
October 16th 2024
Article

Oncology nurses play a crucial role in monitoring the severity and frequency of treatment-related symptoms, particularly nausea.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

breast

Test Predicts Neoadjuvant Treatment Response in TNBC

Chris Ryan
October 14th 2024
Article

The DetermalO identified patients with early-stage triple-negative breast cancer who would benefit from presurgical atezolizumab plus carboplatin and nab-paclitaxel.

The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
January 16th 2023
Podcast

Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.

breast on yellow background

Finding the ‘Right Fit’ for ER+ Breast Cancer After Aromatase Inhibitor AEs

Brielle Benyon
October 8th 2024
Article

A nurse practitioner discussed considerations for managing aromatase inhibitor-related joint pain in patients with breast cancer.

breast

Neoadjuvant ICIs May Improve Efficacy Outcomes in Early-Stage TNBC

Spencer Feldman
September 25th 2024
Article

Neoadjuvant immune checkpoint inhibitors plus chemotherapy also improved efficacy outcomes in PD-L1-positive/ERBB2-negative tumors.

© 2024 MJH Life Sciences

All rights reserved.